Post-treatment bone marrow residual disease > 5% by flow cytometry is highly predictive of short progression-free and overall survival in patients with Waldenström's macroglobulinemia (Q84799627)
Jump to navigation
Jump to search
scientific article published on 01 February 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Post-treatment bone marrow residual disease > 5% by flow cytometry is highly predictive of short progression-free and overall survival in patients with Waldenström's macroglobulinemia |
scientific article published on 01 February 2011 |
Statements
Post-treatment bone marrow residual disease > 5% by flow cytometry is highly predictive of short progression-free and overall survival in patients with Waldenström's macroglobulinemia (English)
A Caballero
R J P Magalhães
J Alonso
L López-Anglada
T Villaescusa
N Puig
J M Hernández
J Fernández-Calvo
A Aguilar
A Martín
R López
B Paiva
B Vidriales
1 February 2011